Literature DB >> 26467302

The utility of endometrial thickness measurement in asymptomatic postmenopausal women with endometrial fluid.

B Seckin1, A S Ozgu-Erdinc1, M Dogan2,3, M Turker4, M N Cicek1.   

Abstract

The aim of this study was to assess the clinical usefulness of sonographic endometrium thickness measurement in asymptomatic postmenopausal women with endometrial fluid collection. Fifty-two asymptomatic postmenopausal women with endometrial fluid, who underwent endometrial sampling were evaluated. Histopathological findings revealed that 25 (48.1%) women had insufficient tissue, 20 (38.4%) had atrophic endometrium and 7 (13.5%) had endometrial polyps. No case of malignancy was found. There was no statistically significant difference between the various histopathological categories (insufficient tissue, atrophic endometrium and polyp) with regard to the mean single-layer endometrial thickness (1.54 ± 0.87, 2.04 ± 1.76 and 1.79 ± 0.69 mm, respectively, p = 0.436). Out of 44 patients with endometrial thickness of less than 3 mm, 38 (86.4%) had atrophic changes or insufficient tissue and 6 (13.6%) had endometrial polyps. In conclusion, if the endometrial thickness is 3 mm or less, endometrial sampling is not necessary in asymptomatic postmenopausal women with endometrial fluid.

Entities:  

Keywords:  Endometrial fluid; endometrial thickness; postmenopausal; ultrasound

Mesh:

Year:  2015        PMID: 26467302     DOI: 10.3109/01443615.2015.1058768

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Clinicopathological and ultrasound features of endometrial cancer in postmenopausal women: a retrospective study in a single institute in South Korea.

Authors:  Hyen Chul Jo; Jong Chul Baek; Seon Mi Lee; Ji Eun Park; In Ae Cho; Joo Hyun Sung
Journal:  Pan Afr Med J       Date:  2021-02-10

2.  Is postmenopausal endometrial fluid collection alone a risk factor for endometrial cancer?

Authors:  Gulin Feykan Yegin Akcay; Emre Erdem Tas; Ayse Filiz Yavuz
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.